Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Metreleptin for Lipodystrophy
Recruiting2 awardsPhase 3
Dallas, Texas
"This trial is an extension of a previous study testing the safety and effectiveness of daily subcutaneous metreleptin treatment in people with partial lipodystrophy. The goal is to evaluate the long
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service